Addrenex to test potential medicines
Published: Wed, Dec. 19, 2007 12:00AM
Modified Wed, Dec. 19, 2007 02:42AM
E-Mail
Print
tool name
closeDURHAM -- Addrenex Pharmaceuticals, a Durham company working on a hypertension treatment, has bought the rights to screen nearly 400 chemicals in the University of Nebraska Medical Center's library for their effectiveness as medicines.
The chemicals all target sites on cells that react with hormones regulating a variety of processes, including blood pressure, mental health, pain and sleep disorders. The agreement allows Addrenex to tap into the library, a gift from Procter and Gamble. Financial details were not released.
More Business
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
